Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
批准号:
10308411
负责人:
GERALD Warren HART
金额:
$49.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-12-01 至 2024-11-30
关键词:
AddressAgingAlzheimer&aposs DiseaseBindingBinding SitesCell NucleusCell physiologyCellsChronic DiseaseCommunicationCytoplasmCytoplasmic GranulesCytoplasmic ProteinDNA Modification MethylasesDataDiabetes MellitusDiabetic mouseDiseaseEIF-2alphaEatingEnzymesEtiologyFoundationsGene ExpressionGenetic TranscriptionGenetic TranslationGlucoseGoalsHeat Stress DisordersHistonesHyperglycemiaIn VitroInvestigationKineticsMalignant NeoplasmsMediatingMessenger RNAMetabolic DiseasesMethodsMitochondrial ProteinsModificationMolecularNerve DegenerationNuclear ProteinsNutrientO-GlcNAc transferaseOryctolagus cuniculusPeptidesPhosphorylationPlayPolyribosomesPost-Translational Protein ProcessingPreparationProcessProteasome InhibitionProtein BiosynthesisProteinsRNARNA Polymerase IIRegulationReticulocytesRetinaRibonucleoproteinsRibosomal ProteinsRibosomesRoleSignal TransductionSiteStressSystemTimeTissuesToxic effectTranslational RegulationTranslationsUbiquitinationWorkbasemRNA Decaymessenger ribonucleoproteinmulticatalytic endopeptidase complexnovelpeptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidasepolypeptideprematurepreventprotein aggregationprotein expressionproteostasisresponsesensorstress granulesugartranscription factortranscriptometranscriptome sequencingtranslation factor
中文摘要
N-乙酰葡糖胺在核上的Ser(Thr)残基上的循环(O-GlcNAc酰化; OGN),
细胞质和线粒体蛋白质作为营养传感器调节信号传导、转录,
细胞生理学异常OGN是糖尿病、癌症和阿尔茨海默病的病因学基础。OGN
几乎调控转录的各个方面,包括RNA聚合酶II、组蛋白、DNA
甲基转移酶和几乎所有的转录因子。我们和其他人最近的研究结果表明,O-
GlcNAc化也调节蛋白质翻译和mRNA利用,但知之甚少。
了解营养物质和压力如何通过OGN调节蛋白质翻译不仅对我们的基础研究至关重要,
了解细胞最重要的过程之一,也是了解机制的关键
潜在的慢性衰老疾病,如糖尿病、癌症和神经退行性疾病。
我们推测,O-GlcNAc对翻译机制中蛋白质的循环调节蛋白质稳态
通过介导蛋白酶体和核糖体机制之间的通讯,
翻译速率和mRNA选择通过动态O-GlcNAc循环对许多核糖体相关蛋白。
我们提出了三个具体的目标,以促进我们对OGN在营养调控中的作用的理解。
目标1将使用最先进的质谱方法来识别新生和成熟的
核糖体相关蛋白和翻译因子被OGN修饰,我们将特别
重点放在那些似乎参与核糖体:蛋白酶体通讯。然后我们将决定
OGN在所选OGN翻译蛋白上的位点水平的功能。目标2将阐明
葡萄糖改变了翻译机器的OGN。使用活HEK 293细胞和兔网织红细胞
翻译系统,我们将通过进行RNA测序分析来确定OGN是否在mRNA选择中起作用。
多聚核糖体制剂。目的3将确定O-GlcNAc转移酶(OGT)
和O-GlcNAcase(OGA)响应于蛋白酶体抑制而快速靶向核糖体。
这些研究不仅阐明了营养物质如何调节蛋白质合成的分子机制,
但它们也是揭示糖尿病中高血糖如何异常改变蛋白质的关键
在许多组织中表达。这些研究揭示的分子机制可能会导致全新的
用于治疗慢性衰老疾病,特别是糖尿病的靶点。
英文摘要
The cycling of N-acetylglucosamine on Ser(Thr) residues (O-GlcNAcylation; OGN) on nuclear,
cytoplasmic and mitochondrial proteins serves as a nutrient sensor to regulate signaling, transcription, and
cellular physiology. Abnormal OGN underlies the etiology of diabetes, cancer and Alzheimer’s disease. OGN
regulates nearly every aspect of transcription, including RNA polymerase II, histones, DNA
methyltransferases, and nearly all transcription factors. Recent findings by us and others indicate that O-
GlcNAcylation also regulates protein translation and mRNA utilization, but much less is known.
Understanding how nutrients and stress regulate protein translation via OGN is not only critical to our basic
understanding of one of the cell’s most vital processes, but also is key to understanding mechanisms
underlying chronic diseases of aging, such as diabetes, cancer and neurodegeneration.
We hypothesize that O-GlcNAc cycling on proteins in the translational machinery regulates proteostasis
by mediating communication between the proteasome and ribosomal machinery, and that nutrients regulate
translation rates and mRNA selection by dynamic O-GlcNAc cycling on many ribosome-associated proteins.
We propose three specific aims to advance our understanding of OGN’s roles in nutrient regulation of
translation: Aim 1 will use state-of-the-art mass spectrometric methods to identify both nascent and mature
ribosome associated proteins and translation factors that are modified by OGN, and we will specifically
focus on those that appear to be involved in ribosome:proteasome communication. We will then determine
the functions of OGN at the site level on selected OGN translation proteins. Aim 2 will elucidate how high
glucose alters the OGN of the translation machinery. Using both live HEK293 cells and a rabbit reticulocyte
translation system, we will determine if OGN plays a role in mRNA selection by performing RNA seq analyses
of polysome preparations. Aim 3 will determine the mechanisms by which the O-GlcNAc transferase (OGT)
and O-GlcNAcase (OGA) are rapidly targeted to ribosomes in response to proteasome inhibition.
These studies are not only elucidating molecular mechanisms of how nutrients regulate protein synthesis,
but they also are key to revealing how hyperglycemia, as occurs in diabetes, abnormally alters protein
expression in many tissues. Molecular mechanisms revealed in these studies will likely lead to totally novel
targets for the treatment of chronic diseases of aging, particularly diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
-
批准号:10533317
-
项目类别:
-
资助金额:$49.78万
-
财政年份:2020
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10458006
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10261390
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10668984
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:9329448
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:9754184
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
"Glycosciences Skills Development "
-
批准号:8183699
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Administrative Core
-
批准号:8183684
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8669110
-
项目类别:
-
资助金额:$251.32万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8072358
-
项目类别:
-
资助金额:$243.63万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Crosstalk Between 0-GlcNAcylation and Phosphorylation in Diabetic Cardiomyopathy
-
批准号:8183667
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8289623
-
项目类别:
-
资助金额:$244.69万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:9067492
-
项目类别:
-
资助金额:$225.94万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8477248
-
项目类别:
-
资助金额:$236.62万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Shared Resource Cores
-
批准号:8183701
-
项目类别:
-
资助金额:$62.86万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8656256
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8853915
-
项目类别:
-
资助金额:$247.05万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Mechanisms of Glucose Toxicity
-
批准号:7762380
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2010
-
负责人:GERALD Warren HART
-
依托单位:
O-GlcNAc:Developing New Tool for Assessment of Glycemia
-
批准号:7491662
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2005
-
负责人:GERALD Warren HART
-
依托单位:
O-GlcNAc:Developing New Tool for Assessment of Glycemia
-
批准号:6928686
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2005
-
负责人:GERALD Warren HART
-
依托单位:
海外基金